Ad is loading...
ACLX
Price
$90.91
Change
+$3.69 (+4.23%)
Updated
Nov 22, 03:14 PM (EDT)
118 days until earnings call
SPRY
Price
$13.63
Change
+$0.25 (+1.87%)
Updated
Nov 22, 03:37 PM (EDT)
118 days until earnings call
Ad is loading...

ACLX vs SPRY

Header iconACLX vs SPRY Comparison
Open Charts ACLX vs SPRYBanner chart's image
Arcellx
Price$90.91
Change+$3.69 (+4.23%)
Volume$100
CapitalizationN/A
ARS Pharmaceuticals
Price$13.63
Change+$0.25 (+1.87%)
Volume$400
CapitalizationN/A
ACLX vs SPRY Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ACLX vs. SPRY commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and SPRY is a StrongSell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (ACLX: $87.22 vs. SPRY: $13.38)
Brand notoriety: ACLX and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 56% vs. SPRY: 69%
Market capitalization -- ACLX: $4.72B vs. SPRY: $1.3B
ACLX [@Biotechnology] is valued at $4.72B. SPRY’s [@Biotechnology] market capitalization is $1.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACLX and SPRY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 3 TA indicator(s) are bullish while SPRY’s TA Score has 3 bullish TA indicator(s).

  • ACLX’s TA Score: 3 bullish, 5 bearish.
  • SPRY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than SPRY.

Price Growth

ACLX (@Biotechnology) experienced а -8.27% price change this week, while SPRY (@Biotechnology) price change was -5.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was -5.02%, and the average quarterly price growth was +3.97%.

Reported Earning Dates

ACLX is expected to report earnings on Mar 20, 2025.

SPRY is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.72B) has a higher market cap than SPRY($1.3B). SPRY YTD gains are higher at: 144.161 vs. ACLX (57.153). ACLX has higher annual earnings (EBITDA): -33.12M vs. SPRY (-60.51M). ACLX has more cash in the bank: 574M vs. SPRY (205M). SPRY has less debt than ACLX: SPRY (102K) vs ACLX (65.3M). ACLX has higher revenues than SPRY: ACLX (156M) vs SPRY (2.57M).
ACLXSPRYACLX / SPRY
Capitalization4.72B1.3B363%
EBITDA-33.12M-60.51M55%
Gain YTD57.153144.16140%
P/E RatioN/AN/A-
Revenue156M2.57M6,075%
Total Cash574M205M280%
Total Debt65.3M102K64,020%
TECHNICAL ANALYSIS
Technical Analysis
ACLXSPRY
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 12 days ago
89%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ETCG12.711.01
+8.63%
Grayscale Ethereum Classic Trust (ETC)
DYLG29.810.31
+1.07%
Global X Dow 30 Covered Call & GrowthETF
XSEP38.790.07
+0.18%
FT Cboe Vest U.S. Eq Enh & ModBufETF-Sep
IVLU27.67N/A
N/A
iShares Edge MSCI Intl Value Factor ETF
EFZ16.65-0.03
-0.21%
ProShares Short MSCI EAFE

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
N/A
BEAM - ACLX
49%
Loosely correlated
-3.72%
RCKT - ACLX
48%
Loosely correlated
-1.92%
RCUS - ACLX
47%
Loosely correlated
-2.33%
MGTX - ACLX
46%
Loosely correlated
+1.72%
CRSP - ACLX
46%
Loosely correlated
-2.05%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-1.25%
LPCN - SPRY
63%
Loosely correlated
+6.16%
INZY - SPRY
44%
Loosely correlated
-3.58%
ACLX - SPRY
41%
Loosely correlated
N/A
OABI - SPRY
39%
Loosely correlated
-1.28%
PLRX - SPRY
39%
Loosely correlated
+0.94%
More